Table 1

Descriptive characteristics of study subjects

XXY (Klinefelter syndrome) (n=27)Controls (n=87)P value†
Age (years)14.7±1.816.9±0.9<0.01*
Race/ethnicity, n (%)0.02
 Non-Hispanic white21 (78)52 (60)
 Hispanic3 (11)31 (36)
 Black3 (11)4 (5)
Height z-score1.3±1.10.2±0.9<0.01*
Weight z-score0.8±1.30.5±1.10.19
BMI z-score0.19±1.550.37±1.180.51
Pubertal stage, n (%)0.17
 Tanner 22 (7.4)1 (1.1)
 Tanner 301 (1.1)
 Tanner 415 (55.6)32 (36.8)
 Tanner 510 (37.0)53 (60.9)
Average daily METs68±2071±160.44
Muscle area (cm3)3175 (2949, 3870)4201 (3571, 5068)<0.01*
Force (kg)30.3 (24.7, 34.9)37.9 (24.3, 32.4)0.51
Triglyceride:HDL ratio2.1 (1.6, 2.6)1.6 (1.2, 2.3)0.03*
Treatment with exogenous testosterone, n (%)13 (48.1)
  • Data presented as mean±SD, median (25%, 75%), or n (%).

  • *Statistically significant difference at an alpha of 0.05.

  • †Comparison between XXY and controls by Welch’s t-test, Wilcoxon rank-sum test, or χ2 test.

  • BMI, body mass index; HDL, high-density lipoprotein; METs, metabolic equivalents.